BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 35428224)

  • 1. Exploring socio-demographic, physical, psychological, and quality of life-related factors related with fear of cancer recurrence in stomach cancer survivors: a cross-sectional study.
    Shin J; Shin DW; Lee J; Hwang J; Lee JE; Cho B; Song YM
    BMC Cancer; 2022 Apr; 22(1):414. PubMed ID: 35428224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence.
    Fardell JE; Jones G; Smith AB; Lebel S; Thewes B; Costa D; Tiller K; Simard S; Feldstain A; Beattie S; McCallum M; ; Butow P
    Psychooncology; 2018 Feb; 27(2):492-499. PubMed ID: 28755462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fear of Cancer Recurrence in peritoneal malignancy patients following treatment: a cross-sectional study.
    Taher R; Carr NJ; Vanderpuye N; Stanford S
    J Cancer Surviv; 2023 Apr; 17(2):300-308. PubMed ID: 35900688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fear of cancer recurrence among cancer survivors in Singapore.
    Mahendran R; Liu J; Kuparasundram S; Simard S; Chan YH; Kua EH; Griva K
    Singapore Med J; 2021 Jun; 62(6):305-310. PubMed ID: 31989183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
    Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
    Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring fear of cancer recurrence in survivors of childhood cancer: Development and preliminary validation of the Fear of Cancer Recurrence Inventory (FCRI)-Child and Parent versions.
    Tutelman PR; Chambers CT; Heathcote LC; Fernandez CV; Flanders A; Patton M; Schulte FSM; Guilcher GMT; Simard S; MacLeod J; Stern M
    Psychooncology; 2022 Jun; 31(6):911-919. PubMed ID: 35018689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial validation of the Danish version of the Fear of Cancer Recurrence Inventory (FCRI) in colorectal cancer patients.
    Hovdenak Jakobsen I; Jeppesen MM; Simard S; Thaysen HV; Laurberg S; Juul T
    J Cancer Surviv; 2018 Dec; 12(6):723-732. PubMed ID: 30128857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors.
    Thewes B; Bell ML; Butow P
    Psychooncology; 2013 Sep; 22(9):2059-63. PubMed ID: 23408595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer-specific symptoms and fear of cancer recurrence among recurrence-free non-small cell lung cancer survivors.
    Lee G; Ahn A; Lee D; Kim TE; Kong S; Kang D; Kim HK; Shim YM; Cho J
    Support Care Cancer; 2024 May; 32(5):322. PubMed ID: 38695959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fear of Cancer Recurrence and Its Negative Impact on Health-Related Quality of Life in Long-term Breast Cancer Survivors.
    Tran TXM; Jung SY; Lee EG; Cho H; Kim NY; Shim S; Kim HY; Kang D; Cho J; Lee E; Chang YJ; Cho H
    Cancer Res Treat; 2022 Oct; 54(4):1065-1073. PubMed ID: 34883553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fear of cancer recurrence in Non- and Hodgkin lymphoma survivors during their first three years of survivorship among French patients.
    Walburg V; Rueter M; Lamy S; Compaci G; Lapeyre-Mestre M; Laurent G; Despas F
    Psychol Health Med; 2019 Aug; 24(7):781-787. PubMed ID: 30714815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between fear of cancer recurrence and quality of life among Chinese cancer survivors: main effect hypothesis and buffering hypothesis.
    Cho D; Lu Q
    Qual Life Res; 2017 Sep; 26(9):2375-2385. PubMed ID: 28455639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring characteristics, predictors, and consequences of fear of cancer recurrence among Asian-American breast cancer survivors.
    Ashing KT; Cho D; Lai L; Yeung S; Young L; Yeon C; Fong Y
    Psychooncology; 2017 Dec; 26(12):2253-2260. PubMed ID: 27992680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.
    Dieng M; Kasparian NA; Cust AE; Costa DSJ; Tran A; Butow PN; Menzies SW; Mann GJ; Morton RL
    JAMA Dermatol; 2018 Jan; 154(1):52-59. PubMed ID: 29188268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fear of cancer recurrence and its predictors among cervical cancer survivors.
    Hanprasertpong J; Geater A; Jiamset I; Padungkul L; Hirunkajonpan P; Songhong N
    J Gynecol Oncol; 2017 Nov; 28(6):e72. PubMed ID: 28758378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fear of cancer recurrence and its predictors and outcomes among cancer survivors: A descriptive correlational study.
    Rha SY; Park JS; Choi YY; Hong B; Lee J
    Eur J Oncol Nurs; 2022 Jun; 58():102138. PubMed ID: 35490660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fear of cancer recurrence: a significant concern among partners of prostate cancer survivors.
    van de Wal M; Langenberg S; Gielissen M; Thewes B; van Oort I; Prins J
    Psychooncology; 2017 Dec; 26(12):2079-2085. PubMed ID: 28317267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of fear of cancer recurrence on healthcare utilization among long-term breast cancer survivors recruited through ECOG-ACRIN trials.
    Vachon E; Krueger E; Champion VL; Haggstrom DA; Cella D; Cohee AA
    Psychooncology; 2021 Mar; 30(3):279-286. PubMed ID: 33022832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fear of cancer recurrence in haematological cancer patients: exploring socio-demographic, psychological, existential and disease-related factors.
    Borreani C; Alfieri S; Farina L; Bianchi E; Corradini P
    Support Care Cancer; 2020 Dec; 28(12):5973-5982. PubMed ID: 32285261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale.
    Custers JAE; Kwakkenbos L; van de Wal M; Prins JB; Thewes B
    Psychooncology; 2018 Nov; 27(11):2609-2615. PubMed ID: 29843189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.